Search results
Josh Groban Will Host the 15th Annual Jimmy Awards
Broadway World· 2 days agoThe Broadway League Foundation just announced that EMMY, two-time TONY, and five-time GRAMMY Award-nominated singer, songwriter, actor, and...
Here's Why Some Shareholders May Not Be Too Generous With GDEX Berhad's (KLSE:GDEX) CEO Compensation...
Simply Wall St. via Yahoo Finance· 1 day agoWhile we don't have analyst forecasts for the company, shareholders might want to examine this...
Leonard Schleifer
Fortune· 2 days agoToday its monoclonal antibodies, particularly Eylea for retinal diseases, are producing major cash injections for the company. Indeed, Eylea is on track for mega-blockbuster
Price Chart for Leading Subscription Video Streaming Services: Updated With New Max Prices
Variety· 1 day agoThe week before the show’s first season premiere in 2022 (and amid the company’s Great Content...
Pruneyard Cinemas in Campbell faces “significant” money challenge, seeks lease rework
San Jose Mercury News· 11 hours agoNow, the most ominous challenge may have arrived: the lease for the Pruneyard Cinemas space. “We are...
5 Top Stocks to Buy in June
Motley Fool via Yahoo Finance· 4 days agoThanks mainly to its CF therapy Trikafta, the company generated revenue of $2.69 billion and a profit of nearly $1.1 billion in the first quarter of...
First Citizens rides growth streak to Fortune 500 - Triangle Business Journal
The Business Journals· 2 days agoAmong the 14 companies making their debut Tuesday on the 70th annual Fortune 500 list is First...
AbbVie (ABBV) Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU
Zacks via Yahoo Finance· 3 days agoAbbVie (ABBV) announces that the EMA's CHMP issued a positive opinion on its regulatory filing...
The Summer Box Office Crisis: Is the Sky Really Falling This Time?
The Hollywood Reporter· 12 hours agoWithin minutes of the actors strike ending on Nov. 9, Ryan Reynolds was making plans to get back to...
3 Dividend Stocks to Double Up on Right Now
Motley Fool via Yahoo Finance· 7 days agoPfizer Once-booming COVID-19 vaccine sales have plunged, dragging down Pfizer's (NYSE: PFE) overall revenue and earnings. The big drugmaker faces a...
